ANAB
AnaptysBio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$56.80
−1.15%Leverage
- Debt / equity
- 21.76x
- Net debt / equity
- 2.27x
- Debt / assets
- 0.84x
- Debt / EBITDA
- 4.74x
- Net debt / EBITDA
- 0.49x
Liquidity & coverage
- Current ratio
- 7.58x
- Quick ratio
- 7.58x
- Cash ratio
- 6.87x
- Interest coverage
- 0.49x
- EBITDA / interest
- 0.71x
- Working capital
- $274.4M
Cash & dividend
- FCF / debt
- 0.02x
- Cash flow / debt
- 0.02x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026